Related references
Note: Only part of the references are listed.The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study
Melanie Racine et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2016)
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
Camelia Frantz et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
THE FIVE PROSPECTIVE OBSERVATIONAL TRIALS OF THE INTERNATIONAL SYSTEMIC SCLEROSIS FP7-HEALTH RESEARCH PROJECT DESSCIPHER: A INTERIM REPORT
M. Frerix et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception
Michael Hughes et al.
RHEUMATOLOGY (2015)
Musculoskeletal involvement in systemic sclerosis
Veronika Lorand et al.
PRESSE MEDICALE (2014)
Linking Physical Function Outcomes in Rheumatology: Performance of a Crosswalk for Converting Health Assessment Questionnaire Scores to Short Form 36 Physical Functioning Scale Scores
Martijn A. H. Oude Voshaar et al.
ARTHRITIS CARE & RESEARCH (2014)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context
Linda Kwakkenbos et al.
BMJ Open (2013)
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database
Florian M. P. Meier et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools
Gemma Strickland et al.
CLINICAL RHEUMATOLOGY (2012)
Effect of Gastrointestinal Manifestations on Quality of Life in 87 Consecutive Patients with Systemic Sclerosis
Mohammed A. Omair et al.
JOURNAL OF RHEUMATOLOGY (2012)
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial
Vibeke Strand et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey
Marielle Bassel et al.
RHEUMATOLOGY (2011)
Measures of Systemic Sclerosis (Scleroderma) Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician- and Patient-Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS)
Janet Pope
ARTHRITIS CARE & RESEARCH (2011)
Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis
L. Mouthon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Health-Related Quality of Life in Systemic Sclerosis: A Systematic Review
Marie Hudson et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study
Karin Franck-Larsson et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations
Robert H. Dworkin et al.
JOURNAL OF PAIN (2008)
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database
U. A. Walker et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
The Health Assessment Questionnaire Disability Index and Scleroderma Health Assessment Questionnaire in Scleroderma Trials: An evaluation of their measurement properties
SR Johnson et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Validation of french version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)
C Georges et al.
CLINICAL RHEUMATOLOGY (2005)
A cross-sectional comparison of three self-reported functional indices in scleroderma
AE Smyth et al.
RHEUMATOLOGY (2003)
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
PA Merkel et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
